Asia Deal Digest, published periodically, is a compilation of some of the largest deals carried out in Asia and Australia.

Japan

Sullivan & Cromwell is representing Sumitovant Biopharma Ltd. and its parent company Sumitomo Pharma Co. Ltd., a Japanese pharmaceutical firm, on the $1.7 billion acquisition of the remaining shares of biotechnology research company Myovant Sciences.